Impact of Port-A-Cath device management in cancer patients with candidaemia

Y. C. Lai, L. J. Huang, T. L. Chen, Y. W. Yang, L. T. Hsiao, H. W. Teng, C. P. Fung, T. J. Chiou, C. H. Tzeng, C. Y. Liu

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


This study investigated the impact of management of a totally implantable central venous access port device, Port-A-Cath (Smith Medical, St. Paul, MN, USA), on the outcome of 98 cancer patients with candidaemia. Port-A-Cath retention was found to be significantly associated with poorer outcome, independent of other significant adverse factors [breakthrough candidaemia, Acute Physiology and Chronic Health Evaluation (APACHE) II score ≥21, and worse Eastern Cooperative Oncology Group (ECOG) performance score (3-4)]. However, retention of Port-A-Cath devices could be considered in patients who do not have definite catheter-related candidaemia, are not using total parenteral nutrition, do not have poor ECOG performance scores or APACHE II scores, and do not have septic shock.

Original languageEnglish
Pages (from-to)281-285
Number of pages5
JournalJournal of Hospital Infection
Issue number4
Publication statusPublished - Dec 2012
Externally publishedYes


  • Cancer
  • Candidaemia
  • Port-A-Cath
  • Removal
  • Retention
  • Totally implantable central venous access port

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Impact of Port-A-Cath device management in cancer patients with candidaemia'. Together they form a unique fingerprint.

Cite this